| Title | Indian Drugs |
| Abbreviation | Indian Drugs |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4) |
| h-index | 32 |
| Overall Rank/Ranking | 24228 |
| SCImago Journal Rank (SJR) | 0.120 |
| Impact Score | 0.19 |
| Publisher | Indian Drug Manufacturers' Association |
| Country | India |
| ISSN | 0019462X |
| Best Quartile | Q4 |
| Coverage History | 1989-2022 |
Indian Drugs is a journal covering the technologies/fields/categories related to Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4). It is published by Indian Drug Manufacturers' Association. The overall rank of Indian Drugs is 24228. According to SCImago Journal Rank (SJR), this journal is ranked 0.120. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 32. The best quartile for this journal is Q4.
The ISSN of Indian Drugs journal is 0019462X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Indian Drugs is cited by a total of 68 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Indian Drugs is 0.19, which is computed in 2023 as per its definition. Indian Drugs IF is increased by a factor of 0.02 and approximate percentage change is 11.76% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Indian Drugs is 0.19. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.19 |
| 2021 | 0.17 |
| 2020 | 0.14 |
| 2019 | 0.14 |
| 2018 | 0.08 |
| 2017 | 0.10 |
| 2016 | 0.08 |
| 2015 | 0.08 |
| 2014 | 0.11 |
Indian Drugs has an h-index of 32. It means 32 articles of this journal have more than 32 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Indian Drugs is 0019462X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Indian Drugs is 24228. According to SCImago Journal Rank (SJR), this journal is ranked 0.120. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.120 |
| 2021 | 0.117 |
| 2020 | 0.121 |
| 2019 | 0.121 |
| 2018 | 0.117 |
| 2017 | 0.129 |
| 2016 | 0.114 |
| 2015 | 0.123 |
| 2014 | 0.130 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 24228 |
| 2021 | 23575 |
| 2020 | 26849 |
| 2019 | 24850 |
| 2018 | 25824 |
| 2017 | 23479 |
| 2016 | 26286 |
| 2015 | 24298 |
| 2014 | 22758 |
Indian Drugs is published by Indian Drug Manufacturers' Association. It's publishing house is located in India. Coverage history of this journal is as following: 1989-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Indian Drugs is Indian Drugs. This abbreviation ('Indian Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Indian Drugs latest impact IF is 0.19. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.19 (2022) and 0.08 (2018), respectively, in the last 9 years. Moreover, its average IS is 0.12 in the previous 9 years.
The Indian Drugs has an SJR (SCImago Journal Rank) of 0.120, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.130 in 2014 and the lowest being 0.114 in 2016. Furthermore, the average SJR of the Indian Drugs over the previous 9-year period stands at 0.12.
The latest h-index of the Indian Drugs is 32.
The Indian Drugs is published by the Indian Drug Manufacturers' Association, with its country of publication being the India.
The Indian Drugs is currently ranked 24228 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 22758 in 2014 and its lowest position of 26849 in 2020.
The standard ISO4 abbreviation for the Indian Drugs is Indian Drugs.
Indian Drugs is classified as a journal that the Indian Drug Manufacturers' Association publishes.
The Indian Drugs encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Indian Drugs is assigned the following International Standard Serial Numbers (ISSN): 0019462X.
The best quartile for the Indian Drugs is Q4 (2022).
The Indian Drugs coverage history can be summarized as follows: 1989-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Indian Journal of Plastic Surgery | journal | 16018 | Thieme Medical Publishers Inc. | 37 | 0.65 |
| Journal of Field Archaeology | journal | 5639 | Maney Publishing | 43 | 2.38 |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 7015 | 49 | 2.14 | |
| International Journal of Mathematical Education in Science and Technology | journal | 10040 | Taylor and Francis Ltd. | 39 | 1.33 |
| Archives of Phytopathology and Plant Protection | journal | 14852 | Taylor and Francis Ltd. | 29 | 1.14 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 15843 | Taylor and Francis Ltd. | 23 | 1.28 |
| Journal of Education and Work | journal | 9268 | Brill Academic Publishers | 43 | 1.93 |
| British Journal of Special Education | journal | 12024 | Wiley-Blackwell Publishing Ltd | 42 | 1.24 |
| International Journal of Research and Method in Education | journal | 5180 | Taylor and Francis Ltd. | 34 | 2.49 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.19 |
| 2021 | 0.17 |
| 2020 | 0.14 |
| 2019 | 0.14 |
| 2018 | 0.08 |
| 2017 | 0.10 |
| 2016 | 0.08 |
| 2015 | 0.08 |
| 2014 | 0.11 |
